Skip to main content
Premium Trial:

Request an Annual Quote

People: Byron Hewett, Larry Gold

Premium

SomaLogic has named Byron Hewett as CEO. Hewett takes replaces Larry Gold, who will continue serving the Boulder, Colo.-based company as chairman of the board. Gold will also work as a full-time adviser, SomaLogic said.

Gold co-founded SomaLogic in 2000 and had served as CEO until Hewett's appointment. In a statement, Gold said that while the protein biomarker discovery and clinical diagnostics company has been successful in its initial goals, it needed "additional leadership with the deep business experience and knowledge to take SomaLogic to the next level," and that Hewett is "the leader we need at this critical stage of our company's growth."

Hewett most recently was chairman and CEO of Biobehavioral Diagnostics. He previously was president and CEO of Immunicon and senior vice president of sales and marketing and general manager, North America, for Qiagen. He also has held leadership posts at Abbott Diagnostics, Chiron/Bayer, and BioCircuits.

The Scan

Booster for At-Risk

The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people over 65 or at increased risk.

Preprints OK to Mention Again

Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications.

Hundreds of Millions More to Share

The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post.

Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia

In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.